Search

Your search keyword '"Baron, Marie Hélène"' showing total 155 results
Start Over Author "Baron, Marie Hélène"
155 results on '"Baron, Marie Hélène"'

1. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

Author

McCormack, M, Whitmarsh, K, Allerton, R, Gregory, D, Symonds, P, Hoskin, PJ, Adusumalli, M, Anand, A, Wade, R, Stewart, A, Taylor, W, Lutgens, LCHW, Hollema, H, Pras, E, Snyers, A, Westerveld, GH, Jobsen, JJ, Slot, A, Mens, JM, Stam, TC, Van Triest, B, Van der Steen-Banasik, EM, De Winter, KAJ, Quinn, MA, Kolodziej, I, Pyman, J, Johnson, C, Capp, A, Fossati, R, Colombo, A, Carinelli, S, Ferrero, A, Artioli, G, Davidson, C, McLachlin, CM, Ghatage, P, Rittenberg, PVC, Souhami, L, Thomas, G, Duvillard, P, Berton-Rigaud, D, Tubiana-Mathieu, N, de Boer, Stephanie M, Powell, Melanie E, Mileshkin, Linda, Katsaros, Dionyssios, Bessette, Paul, Haie-Meder, Christine, Ottevanger, Petronella B, Ledermann, Jonathan A, Khaw, Pearly, D'Amico, Romerai, Fyles, Anthony, Baron, Marie-Helene, Jürgenliemk-Schulz, Ina M, Kitchener, Henry C, Nijman, Hans W, Wilson, Godfrey, Brooks, Susan, Gribaudo, Sergio, Provencher, Diane, Hanzen, Chantal, Kruitwagen, Roy F, Smit, Vincent T H B M, Singh, Naveena, Do, Viet, Lissoni, Andrea, Nout, Remi A, Feeney, Amanda, Verhoeven-Adema, Karen W, Putter, Hein, and Creutzberg, Carien L

Published
2019
Full Text
View/download PDF

2. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

Author

McCormack, Mary, Whitmarsh, Karen, Allerton, Rozenn, Gregory, Deborah, Symonds, Paul, Hoskin, Peter J., Adusumalli, Madhavi, Anand, Anjana, Wade, Robert, Stewart, Alexandra, Taylor, Wendy, Kruitwagen, Roy F.P.M., Hollema, Harry, Pras, Elizabeth, Snyers, An, Stalpers, Lukas, Jobsen, Jan J., Slot, Annerie, Mens, Jan-Willem M., Stam, Tanja C., Van Triest, Baukelien, Van der Steen - Banasik, Elzbieta M., De Winter, Karin A.J., Quinn, Michael A., Kolodziej, Ilka, Pyman, Jan, Johnson, Carol, Capp, Anne, Fossati, Roldano, Gribaudo, Sergio, Lissoni, Andrea A., Ferrero, Annamaria, Artioli, Grazia, Davidson, Cathy, McLachlin, C. Meg, Ghatage, Prafull, Rittenberg, Paula V.C., Souhami, Luis, Thomas, Gillian, Duvillard, Pierre, Berton-Rigaud, Dominique, Tubiana-Mathieu, Nicole, de Boer, Stephanie M, Powell, Melanie E, Mileshkin, Linda, Katsaros, Dionyssios, Bessette, Paul, Haie-Meder, Christine, Ottevanger, Petronella B, Ledermann, Jonathan A, Khaw, Pearly, Colombo, Alessandro, Fyles, Anthony, Baron, Marie-Helene, Jürgenliemk-Schulz, Ina M, Kitchener, Henry C, Nijman, Hans W, Wilson, Godfrey, Brooks, Susan, Carinelli, Silvestro, Provencher, Diane, Hanzen, Chantal, Lutgens, Ludy C H W, Smit, Vincent T H B M, Singh, Naveena, Do, Viet, D'Amico, Romerai, Nout, Remi A, Feeney, Amanda, Verhoeven-Adema, Karen W, Putter, Hein, and Creutzberg, Carien L

Published
2018
Full Text
View/download PDF

3. Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial

Author

de Boer, Stephanie M, Powell, Melanie E, Mileshkin, Linda, Katsaros, Dionyssios, Bessette, Paul, Haie-Meder, Christine, Ottevanger, Petronella B, Ledermann, Jonathan A, Khaw, Pearly, Colombo, Alessandro, Fyles, Anthony, Baron, Marie-Helene, Kitchener, Henry C, Nijman, Hans W, Kruitwagen, Roy F, Nout, Remi A, Verhoeven-Adema, Karen W, Smit, Vincent T, Putter, Hein, and Creutzberg, Carien L

Published
2016
Full Text
View/download PDF

4. Survey on current cognitive practices within the European Low-Grade Glioma Network: towards a European assessment protocol

Author

Rofes, Adrià, Mandonnet, Emmanuel, Godden, John, Baron, Marie Hélène, Colle, Henry, Darlix, Amelie, de Aguiar, Vânia, Duffau, Hugues, Herbet, Guillaume, Klein, Martin, Lubrano, Vincent, Martino, Juan, Mathew, Ryan, Miceli, Gabriele, Moritz-Gasser, Sylvie, Pallud, Johan, Papagno, Costanza, Rech, Fabien, Robert, Erik, Rutten, Geert-Jan, Santarius, Thomas, Satoer, Djaina, Sierpowska, Joanna, Smits, Anja, Skrap, Miran, Spena, Giannantonio, Visch, Evy, De Witte, Elke, Zetterling, Maria, and Wager, Michel

Published
2017
Full Text
View/download PDF

6. Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy

Author

MS Radiotherapie, Cancer, Wortman, Bastiaan G., Post, Cathalijne C.B., Powell, Melanie E., Khaw, Pearly, Fyles, Anthony, D'Amico, Romerai, Haie-Meder, Christine, Jürgenliemk-Schulz, Ina M., McCormack, Mary, Do, Viet, Katsaros, Dionyssios, Bessette, Paul, Baron, Marie Hélène, Nout, Remi A., Whitmarsh, Karen, Mileshkin, Linda, Lutgens, Ludy C.H.W., Kitchener, Henry C., Brooks, Susan, Nijman, Hans W., Astreinidou, Eleftheria, Putter, Hein, Creutzberg, Carien L., de Boer, Stephanie M., MS Radiotherapie, Cancer, Wortman, Bastiaan G., Post, Cathalijne C.B., Powell, Melanie E., Khaw, Pearly, Fyles, Anthony, D'Amico, Romerai, Haie-Meder, Christine, Jürgenliemk-Schulz, Ina M., McCormack, Mary, Do, Viet, Katsaros, Dionyssios, Bessette, Paul, Baron, Marie Hélène, Nout, Remi A., Whitmarsh, Karen, Mileshkin, Linda, Lutgens, Ludy C.H.W., Kitchener, Henry C., Brooks, Susan, Nijman, Hans W., Astreinidou, Eleftheria, Putter, Hein, Creutzberg, Carien L., and de Boer, Stephanie M.

Published
2022

7. Initial PCV Chemotherapy Followed by Radiotherapy Is Associated With a Prolonged Response But Late Neurotoxicity in 20 Diffuse Low-Grade Glioma Patients

Author

Blonski, Marie, primary, Obara, Tiphaine, additional, Brzenczek, Cyril, additional, Pouget, Celso, additional, Dillier, Céline, additional, Meyer, Mylène, additional, Lavigne, Laura, additional, Forthoffer, Natacha, additional, Broussois, Aurélie, additional, Gauchotte, Guillaume, additional, Baron, Marie-Hélène, additional, Rech, Fabien, additional, Mézières, Sophie, additional, Gaudeau, Yann, additional, Verger, Antoine, additional, Vogin, Guillaume, additional, Anxionnat, René, additional, Moureaux, Jean-Marie, additional, and Taillandier, Luc, additional

Published
2022
Full Text
View/download PDF

10. Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy

Author

Wortman, Bastiaan G., primary, Post, Cathalijne C.B., additional, Powell, Melanie E., additional, Khaw, Pearly, additional, Fyles, Anthony, additional, D'Amico, Romerai, additional, Haie-Meder, Christine, additional, Jürgenliemk-Schulz, Ina M., additional, McCormack, Mary, additional, Do, Viet, additional, Katsaros, Dionyssios, additional, Bessette, Paul, additional, Baron, Marie Hélène, additional, Nout, Remi A., additional, Whitmarsh, Karen, additional, Mileshkin, Linda, additional, Lutgens, Ludy C.H.W., additional, Kitchener, Henry C., additional, Brooks, Susan, additional, Nijman, Hans W., additional, Astreinidou, Eleftheria, additional, Putter, Hein, additional, Creutzberg, Carien L., additional, and de Boer, Stephanie M., additional

Published
2022
Full Text
View/download PDF

13. Long-term toxicity and health-related quality of life after adjuvant chemoradiotherapy or radiotherapy alone for high-risk endometrial cancer in the randomised PORTEC-3 trial

Author

Post, C, de Boer, S, Powell, M, Mileshkin, L, Katsaros, D, Bessette, P, Haie-Meder, C, Ottevanger, N, Ledermann, J, Khaw, P, D'Amico, R, Fyles, A, Baron, M, Kitchener, H, Nijman, H, Lutgens, L, Brooks, S, Jürgenliemk-Schulz, I, Feeney, A, Goss, G, Fossati, R, Ghatage, P, Leary, A, Do, V, Lissoni, A, Mccormack, M, Nout, R, Verhoeven-Adema, K, Smit, V, Putter, H, Creutzberg, C, Post, Cathalijne C B, de Boer, Stephanie M, Powell, Melanie E, Mileshkin, Linda, Katsaros, Dionyssios, Bessette, Paul, Haie-Meder, Christine, Ottevanger, Nelleke P B, Ledermann, Jonathan A, Khaw, Pearly, D'Amico, Romerai, Fyles, Anthony, Baron, Marie Hélène, Kitchener, Henry C, Nijman, Hans W, Lutgens, Ludy C H W, Brooks, Susan, Jürgenliemk-Schulz, Ina M, Feeney, Amanda, Goss, Geraldine, Fossati, Roldano, Ghatage, Prafull, Leary, Alexandra, Do, Viet, Lissoni, Andrea A, McCormack, Mary, Nout, Remi A, Verhoeven-Adema, Karen W, Smit, Vincent T H B M, Putter, Hein, Creutzberg, Carien L, Post, C, de Boer, S, Powell, M, Mileshkin, L, Katsaros, D, Bessette, P, Haie-Meder, C, Ottevanger, N, Ledermann, J, Khaw, P, D'Amico, R, Fyles, A, Baron, M, Kitchener, H, Nijman, H, Lutgens, L, Brooks, S, Jürgenliemk-Schulz, I, Feeney, A, Goss, G, Fossati, R, Ghatage, P, Leary, A, Do, V, Lissoni, A, Mccormack, M, Nout, R, Verhoeven-Adema, K, Smit, V, Putter, H, Creutzberg, C, Post, Cathalijne C B, de Boer, Stephanie M, Powell, Melanie E, Mileshkin, Linda, Katsaros, Dionyssios, Bessette, Paul, Haie-Meder, Christine, Ottevanger, Nelleke P B, Ledermann, Jonathan A, Khaw, Pearly, D'Amico, Romerai, Fyles, Anthony, Baron, Marie Hélène, Kitchener, Henry C, Nijman, Hans W, Lutgens, Ludy C H W, Brooks, Susan, Jürgenliemk-Schulz, Ina M, Feeney, Amanda, Goss, Geraldine, Fossati, Roldano, Ghatage, Prafull, Leary, Alexandra, Do, Viet, Lissoni, Andrea A, McCormack, Mary, Nout, Remi A, Verhoeven-Adema, Karen W, Smit, Vincent T H B M, Putter, Hein, and Creutzberg, Carien L

Abstract

Background: The survival results of the PORTEC-3 trial showed a significant improvement in both overall and failure-free survival with chemoradiotherapy versus pelvic radiotherapy alone. The present analysis was performed to compare long-term adverse events (AE) and health-related quality of life (HRQOL). Patients and methods: 660 women with high-risk endometrial cancer were randomly assigned to receive chemoradiotherapy (2 concurrent cycles of cisplatin followed by 4 cycles of carboplatin/paclitaxel) or radiotherapy alone. Toxicity was graded using CTCAE v3.0. HRQOL was measured using EORTC QLQ-C30 and CX24/OV28-subscales and compared to normative-data. An as-treated analysis was performed. Results: Median follow up was 74.6 months; 574 (87%) patients were evaluable for HRQOL. At 5 years, grade ≥2 AE were scored for 78 (38%) patients who had received chemoradiotherapy versus 46 (24%) who had received radiotherapy (p=0.008). Grade 3 AE did not differ significantly between the groups (8% vs 5%, p=0.18) at 5 years, and only one new late grade 4 toxicity had been reported. At 3 and 5 years, sensory neuropathy toxicity grade ≥2 persisted after chemoradiotherapy in 6% (vs 0% after radiotherapy, p<0.001) and more patients reported significant tingling or numbness at HRQOL (27% vs 8%, p<0.001 at 3 years; 24% vs 9%, p=0.002 at 5 years). Until 3 years, more patients who had chemoradiotherapy reported limb weakness (21% vs 5%, p<0.001) and lower physical (79 vs 87, p<0.001) and role functioning (78 vs 88, p<0.001) scores. Both treatment groups reported similar long-term global health/QOL scores, which were better than those of the normative-population. Conclusion: This study shows a long-lasting, clinically relevant, negative impact of chemoradiotherapy on toxicity and HRQOL, most importantly persistent peripheral sensory neuropathy. Physical and role functioning impairments were seen until 3 years. These long-term data are essential for patient information and

Published
2021

14. Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial

Author

MS Radiotherapie, Cancer, Post, Cathalijne C.B., de Boer, Stephanie M., Powell, Melanie E., Mileshkin, Linda, Katsaros, Dionyssios, Bessette, Paul, Haie-Meder, Christine, Ottevanger, Nelleke (P ).B., Ledermann, Jonathan A., Khaw, Pearly, D'Amico, Romerai, Fyles, Anthony, Baron, Marie Hélène, Kitchener, Henry C., Nijman, Hans W., Lutgens, Ludy C.H.W., Brooks, Susan, Jürgenliemk-Schulz, Ina M., Feeney, Amanda, Goss, Geraldine, Fossati, Roldano, Ghatage, Prafull, Leary, Alexandra, Do, Viet, Lissoni, Andrea A., McCormack, Mary, Nout, Remi A., Verhoeven-Adema, Karen W., Smit, Vincent T.H.B.M., Putter, Hein, Creutzberg, Carien L., MS Radiotherapie, Cancer, Post, Cathalijne C.B., de Boer, Stephanie M., Powell, Melanie E., Mileshkin, Linda, Katsaros, Dionyssios, Bessette, Paul, Haie-Meder, Christine, Ottevanger, Nelleke (P ).B., Ledermann, Jonathan A., Khaw, Pearly, D'Amico, Romerai, Fyles, Anthony, Baron, Marie Hélène, Kitchener, Henry C., Nijman, Hans W., Lutgens, Ludy C.H.W., Brooks, Susan, Jürgenliemk-Schulz, Ina M., Feeney, Amanda, Goss, Geraldine, Fossati, Roldano, Ghatage, Prafull, Leary, Alexandra, Do, Viet, Lissoni, Andrea A., McCormack, Mary, Nout, Remi A., Verhoeven-Adema, Karen W., Smit, Vincent T.H.B.M., Putter, Hein, and Creutzberg, Carien L.

Published
2021

15. Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial

Author

Post, Cathalijne C.B., primary, de Boer, Stephanie M., additional, Powell, Melanie E., additional, Mileshkin, Linda, additional, Katsaros, Dionyssios, additional, Bessette, Paul, additional, Haie-Meder, Christine, additional, Ottevanger, Nelleke (P.) B., additional, Ledermann, Jonathan A., additional, Khaw, Pearly, additional, D'Amico, Romerai, additional, Fyles, Anthony, additional, Baron, Marie Hélène, additional, Kitchener, Henry C., additional, Nijman, Hans W., additional, Lutgens, Ludy C.H.W., additional, Brooks, Susan, additional, Jürgenliemk-Schulz, Ina M., additional, Feeney, Amanda, additional, Goss, Geraldine, additional, Fossati, Roldano, additional, Ghatage, Prafull, additional, Leary, Alexandra, additional, Do, Viet, additional, Lissoni, Andrea A., additional, McCormack, Mary, additional, Nout, Remi A., additional, Verhoeven-Adema, Karen W., additional, Smit, Vincent T.H.B.M., additional, Putter, Hein, additional, and Creutzberg, Carien L., additional

Published
2021
Full Text
View/download PDF

16. Epileptic seizures in diffuse low-grade gliomas in adults

Author

Pallud, Johan, Audureau, Etienne, Blonski, Marie, Sanai, Nader, Bauchet, Luc, Fontaine, Denys, Mandonnet, Emmanuel, Dezamis, Edouard, Psimaras, Dimitri, Guyotat, Jacques, Peruzzi, Philippe, Page, Philippe, Gal, Beatriz, Párraga, Eduardo, Baron, Marie-Hélène, Vlaicu, Michaela, Guillevin, Rémy, Devaux, Bertrand, Duffau, Hugues, Taillandier, Luc, Capelle, Laurent, and Huberfeld, Gilles

Published
2014
Full Text
View/download PDF

27. Chemotherapy and diffuse low-grade gliomas: a survey within the European Low-Grade Glioma Network

Author

Darlix, Amélie, primary, Mandonnet, Emmanuel, additional, Freyschlag, Christian F, additional, Pinggera, Daniel, additional, Forster, Marie-Therese, additional, Voss, Martin, additional, Steinbach, Joachim, additional, Loughrey, Carmel, additional, Goodden, John, additional, Banna, Giuseppe, additional, Di Blasi, Concetta, additional, Foroglou, Nicolas, additional, Hottinger, Andreas F, additional, Baron, Marie-Hélène, additional, Pallud, Johan, additional, Duffau, Hugues, additional, Rutten, Geert-Jan, additional, Almairac, Fabien, additional, Fontaine, Denys, additional, Taillandier, Luc, additional, Pessanha Viegas, Catarina, additional, Albuquerque, Luisa, additional, von Campe, Gord, additional, Urbanic-Purkart, Tadeja, additional, and Blonski, Marie, additional

Published
2018
Full Text
View/download PDF

28. Extent of Resection and Residual Tumor Thresholds for Postoperative Total Seizure Freedom in Epileptic Adult Patients Harboring a Supratentorial Diffuse Low-Grade Glioma

Author

Still, Megan E H, primary, Roux, Alexandre, additional, Huberfeld, Gilles, additional, Bauchet, Luc, additional, Baron, Marie-Hélène, additional, Fontaine, Denys, additional, Blonski, Marie, additional, Mandonnet, Emmanuel, additional, Guillevin, Remy, additional, Guyotat, Jacques, additional, Taillandier, Luc, additional, Capelle, Laurent, additional, Duffau, Hugues, additional, and Pallud, Johan, additional

Published
2018
Full Text
View/download PDF

29. Chemotherapy and diffuse low-grade gliomas : a survey within the European Low-Grade Glioma Network

Author

Darlix, Amélie, Mandonnet, Emmanuel, Freyschlag, Christian Franz, Pinggera, Daniel, Forster, Marie-Thérèse, Voß, Martin, Steinbach, Joachim Peter, Loughrey, Carmel, Goodden, John, Banna, Giuseppe, Di Blasi, Concetta, Foroglou, Nicolas, Hottinger, Andreas F., Baron, Marie-Hélène, Pallud, Johan, Duffau, Hugues, Rutten, Geert-Jan, Almairac, Fabien, Fontaine, Denys, Taillandier, Luc, Viegas, Catarina, Albuquerque, Luisa, Campe, Gord von, Urbanic Purkart, Tadeja, Blonski, Marie, Darlix, Amélie, Mandonnet, Emmanuel, Freyschlag, Christian Franz, Pinggera, Daniel, Forster, Marie-Thérèse, Voß, Martin, Steinbach, Joachim Peter, Loughrey, Carmel, Goodden, John, Banna, Giuseppe, Di Blasi, Concetta, Foroglou, Nicolas, Hottinger, Andreas F., Baron, Marie-Hélène, Pallud, Johan, Duffau, Hugues, Rutten, Geert-Jan, Almairac, Fabien, Fontaine, Denys, Taillandier, Luc, Viegas, Catarina, Albuquerque, Luisa, Campe, Gord von, Urbanic Purkart, Tadeja, and Blonski, Marie

Abstract

Background: Diffuse low-grade gliomas (DLGGs) are rare and incurable tumors. Whereas maximal safe, functional-based surgical resection is the first-line treatment, the timing and choice of further treatments (chemotherapy, radiation therapy, or combined treatments) remain controversial. Methods: An online survey on the management of DLGG patients was sent to 28 expert centers from the European Low-Grade Glioma Network (ELGGN) in May 2015. It contained 40 specific questions addressing the modalities of use of chemotherapy in these patients. Results: The survey demonstrated a significant heterogeneity in practice regarding the initial management of DLGG patients and the use of chemotherapy. Interestingly, radiation therapy combined with the procarbazine, CCNU (lomustine), and vincristine regimen has not imposed itself as the gold-standard treatment after surgery, despite the results of the Radiation Therapy Oncology Group 9802 study. Temozolomide is largely used as first-line treatment after surgical resection for high-risk DLGG patients, or at progression. Conclusions: The heterogeneity in the management of patients with DLGG demonstrates that many questions regarding the postoperative strategy and the use of chemotherapy remain unanswered. Our survey reveals a high recruitment potential within the ELGGN for retrospective or prospective studies to generate new data regarding these issues.

Published
2018

32. Chemotherapy and diffuse low-grade gliomas: a survey within the European Low-Grade Glioma Network.

Author

Darlix, Amélie, Mandonnet, Emmanuel, Freyschlag, Christian F, Pinggera, Daniel, Forster, Marie-Therese, Voss, Martin, Steinbach, Joachim, Loughrey, Carmel, Goodden, John, Banna, Giuseppe, Blasi, Concetta Di, Foroglou, Nicolas, Hottinger, Andreas F, Baron, Marie-Hélène, Pallud, Johan, Duffau, Hugues, Rutten, Geert-Jan, Almairac, Fabien, Fontaine, Denys, and Taillandier, Luc

Subjects
GLIOMAS, THERAPEUTICS, CANCER chemotherapy, OLIGODENDROGLIOMAS, GROUP psychotherapy, TEMOZOLOMIDE, RADIOTHERAPY
Abstract

Background Diffuse low-grade gliomas (DLGGs) are rare and incurable tumors. Whereas maximal safe, functional-based surgical resection is the first-line treatment, the timing and choice of further treatments (chemotherapy, radiation therapy, or combined treatments) remain controversial. Methods An online survey on the management of DLGG patients was sent to 28 expert centers from the European Low-Grade Glioma Network (ELGGN) in May 2015. It contained 40 specific questions addressing the modalities of use of chemotherapy in these patients. Results The survey demonstrated a significant heterogeneity in practice regarding the initial management of DLGG patients and the use of chemotherapy. Interestingly, radiation therapy combined with the procarbazine, CCNU (lomustine), and vincristine regimen has not imposed itself as the gold-standard treatment after surgery, despite the results of the Radiation Therapy Oncology Group 9802 study. Temozolomide is largely used as first-line treatment after surgical resection for high-risk DLGG patients, or at progression. Conclusions The heterogeneity in the management of patients with DLGG demonstrates that many questions regarding the postoperative strategy and the use of chemotherapy remain unanswered. Our survey reveals a high recruitment potential within the ELGGN for retrospective or prospective studies to generate new data regarding these issues. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

33. Epileptic seizures in diffuse low-grade gliomas in adults

Author

Pallud, Johan, primary, Audureau, Etienne, additional, Blonski, Marie, additional, Sanai, Nader, additional, Bauchet, Luc, additional, Fontaine, Denys, additional, Mandonnet, Emmanuel, additional, Dezamis, Edouard, additional, Psimaras, Dimitri, additional, Guyotat, Jacques, additional, Peruzzi, Philippe, additional, Page, Philippe, additional, Gal, Beatriz, additional, Párraga, Eduardo, additional, Baron, Marie-Hélène, additional, Vlaicu, Michaela, additional, Guillevin, Rémy, additional, Devaux, Bertrand, additional, Duffau, Hugues, additional, Taillandier, Luc, additional, Capelle, Laurent, additional, and Huberfeld, Gilles, additional

Published
2013
Full Text
View/download PDF

34. Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases

Author

Capelle, Laurent, primary, Fontaine, Denys, additional, Mandonnet, Emmanuel, additional, Taillandier, Luc, additional, Golmard, Jean Louis, additional, Bauchet, Luc, additional, Pallud, Johan, additional, Peruzzi, Philippe, additional, Baron, Marie Hélène, additional, Kujas, Michèle, additional, Guyotat, Jacques, additional, Guillevin, Remi, additional, Frenay, Marc, additional, Taillibert, Sophie, additional, Colin, Philippe, additional, Rigau, Valérie, additional, Vandenbos, Fanny, additional, Pinelli, Catherine, additional, Duffau, Hugues, additional, and _, _, additional

Published
2013
Full Text
View/download PDF

35. Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas

Author

Pallud, Johan, primary, Blonski, Marie, additional, Mandonnet, Emmanuel, additional, Audureau, Etienne, additional, Fontaine, Denys, additional, Sanai, Nader, additional, Bauchet, Luc, additional, Peruzzi, Philippe, additional, Frénay, Marc, additional, Colin, Philippe, additional, Guillevin, Rémy, additional, Bernier, Valérie, additional, Baron, Marie-Hélène, additional, Guyotat, Jacques, additional, Duffau, Hugues, additional, Taillandier, Luc, additional, and Capelle, Laurent, additional

Published
2013
Full Text
View/download PDF

37. Natural history of incidental world health organization grade II gliomas

Author

Pallud, Johan, primary, Fontaine, Denys, additional, Duffau, Hugues, additional, Mandonnet, Emmanuel, additional, Sanai, Nader, additional, Taillandier, Luc, additional, Peruzzi, Philippe, additional, Guillevin, Rémy, additional, Bauchet, Luc, additional, Bernier, Valérie, additional, Baron, Marie‐Hélène, additional, Guyotat, Jacques, additional, and Capelle, Laurent, additional

Published
2010
Full Text
View/download PDF

39. Prognostic significance of imaging contrast enhancement for WHO grade II gliomas

Author

Pallud, Johan, primary, Capelle, Laurent, additional, Taillandier, Luc, additional, Fontaine, Denys, additional, Mandonnet, Emmanuel, additional, Guillevin, Rémy, additional, Bauchet, Luc, additional, Peruzzi, Philippe, additional, Laigle-Donadey, Florence, additional, Kujas, Michèle, additional, Guyotat, Jacques, additional, Baron, Marie-Hélène, additional, Mokhtari, Karima, additional, and Duffau, Hugues, additional

Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results